These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31142325)

  • 1. Content validity of the National Comprehensive Cancer Network - Functional Assessment of Cancer Therapy - Breast Cancer Symptom Index (NFBSI-16) and Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form with advanced breast cancer patients.
    Krohe M; Tang DH; Klooster B; Revicki D; Galipeau N; Cella D
    Health Qual Life Outcomes; 2019 May; 17(1):92. PubMed ID: 31142325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priority symptoms in advanced breast cancer: development and initial validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16).
    Garcia SF; Rosenbloom SK; Beaumont JL; Merkel D; Von Roenn JH; Rao D; Cella D
    Value Health; 2012 Jan; 15(1):183-90. PubMed ID: 22264987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity, reliability, responsiveness, and clinically meaningful change threshold estimates of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16).
    Clarke NA; Wong B; Lawrance R; Ingelgård A; Griebsch I; Cella D; Trigg A
    J Patient Rep Outcomes; 2024 Aug; 8(1):97. PubMed ID: 39145900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative concept elicitation and cognitive debriefing interviews of symptoms, impacts and selected customized PROMIS
    Findley A; Middlehurst JM; Howse CA; Clifford MJ; Neill W; Tatlock S; Chen WH; Bracher MG; Patel DS
    J Patient Rep Outcomes; 2023 Apr; 7(1):39. PubMed ID: 37079188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Analysis of Paper-Based and Web-Based Versions of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16) Questionnaire in Breast Cancer Patients: Randomized Crossover Study.
    Ma J; Zou Z; Pazo EE; Moutari S; Liu Y; Jin F
    JMIR Med Inform; 2021 Mar; 9(3):e18269. PubMed ID: 33650978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID).
    Hareendran A; Mannix S; Skalicky A; Bayliss M; Blumenfeld A; Buse DC; Desai PR; Ortmeier BG; Sapra S
    Health Qual Life Outcomes; 2017 Nov; 15(1):224. PubMed ID: 29149901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refining and supplementing candidate measures of psychological well-being for the NIH PROMIS®: qualitative results from a mixed cancer sample.
    Salsman JM; Park CL; Hahn EA; Snyder MA; George LS; Steger MF; Merluzzi T; Cella D
    Qual Life Res; 2018 Sep; 27(9):2471-2476. PubMed ID: 29926344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PROMIS evaluation for head and neck cancer patients: a comprehensive quality-of-life outcomes assessment tool.
    Stachler RJ; Schultz LR; Nerenz D; Yaremchuk KL
    Laryngoscope; 2014 Jun; 124(6):1368-76. PubMed ID: 24719292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and measurement precision of the PROMIS physical function item bank and a content validity-driven 20-item short form in rheumatoid arthritis compared with traditional measures.
    Oude Voshaar MA; Ten Klooster PM; Glas CA; Vonkeman HE; Taal E; Krishnan E; Bernelot Moens HJ; Boers M; Terwee CB; van Riel PL; van de Laar MA
    Rheumatology (Oxford); 2015 Dec; 54(12):2221-9. PubMed ID: 26224306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical function metric over measure: An illustration with the Patient-Reported Outcomes Measurement Information System (PROMIS) and the Functional Assessment of Cancer Therapy (FACT).
    Kaat AJ; Schalet BD; Rutsohn J; Jensen RE; Cella D
    Cancer; 2018 Jan; 124(1):153-160. PubMed ID: 28885707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment.
    Herman JM; Kitchen H; Degboe A; Aldhouse NVJ; Trigg A; Hodgin M; Narang A; Johnson CD
    Qual Life Res; 2019 Nov; 28(11):2929-2939. PubMed ID: 31273624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What questionnaires to use when measuring quality of life in sacral tumor patients: the updated sacral tumor survey.
    van Wulfften Palthe ODR; Janssen SJ; Wunder JS; Ferguson PC; Wei G; Rose PS; Yaszemski MJ; Sim FH; Boland PJ; Healey JH; Hornicek FJ; Schwab JH
    Spine J; 2017 May; 17(5):636-644. PubMed ID: 27856381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative and psychometric approaches to evaluate the PROMIS pain interference and sleep disturbance item banks for use in patients with rheumatoid arthritis.
    Becker B; Raymond K; Hawkes C; Foster AM; Lovley A; Saucier C; Rizio AA; Bjorner JB; Kosinski M
    J Patient Rep Outcomes; 2021 Jul; 5(1):52. PubMed ID: 34228217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients.
    Jensen RE; Potosky AL; Reeve BB; Hahn E; Cella D; Fries J; Smith AW; Keegan TH; Wu XC; Paddock L; Moinpour CM
    Qual Life Res; 2015 Oct; 24(10):2333-44. PubMed ID: 25935353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative study of patients with venous malformations: symptom experiences and content validity of patient-reported outcome measures.
    England RW; Bailey CR; Anatchkova MD; Skalicky AM; Meissner MH; Rosenblatt M; Gelhorn HL; Weiss CR
    Qual Life Res; 2020 Jun; 29(6):1707-1719. PubMed ID: 32020564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of Patient-Reported Outcomes Measurement Information System to assess quality of life among patients with breast cancer initiating care at an academic center.
    Matthys MB; Dempsey AM; Melisko ME; Dreher N; Che ML; Van't Veer LJ; Esserman LJ; Basu A
    Cancer; 2021 Jul; 127(13):2342-2349. PubMed ID: 33957704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS)-57 and -29 item short forms among kidney transplant recipients.
    Tang E; Ekundayo O; Peipert JD; Edwards N; Bansal A; Richardson C; Bartlett SJ; Howell D; Li M; Cella D; Novak M; Mucsi I
    Qual Life Res; 2019 Mar; 28(3):815-827. PubMed ID: 30467780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.
    McCarrier KP; Atkinson TM; DeBusk KP; Liepa AM; Scanlon M; Coons SJ;
    Clin Ther; 2016 Apr; 38(4):794-810. PubMed ID: 27041408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD).
    IsHak WW; Pan D; Steiner AJ; Feldman E; Mann A; Mirocha J; Danovitch I; Melmed GY
    Inflamm Bowel Dis; 2017 May; 23(5):798-803. PubMed ID: 28301432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.